Intent to Sole Source - Olink Reagents

The National Institutes of Health, Clinical Center (NIH-CC) issued a notice of intent to negotiate a sole source contract with Olink Proteomics Inc. for the procurement of proprietary reagents. This requirement is classified under NAICS code 325414 for Biological Product (except Diagnostic) Manufacturing and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. There is no set-aside assigned to this action, which is identified by solicitation number NOI-CC-OLAO-26-006363 and slated for performance in Bethesda, Maryland.

The acquisition is necessary because Olink Proteomics Inc. is the manufacturer of the Q100 Instrument and the only source for compatible, validated reagents required for its operation. The government has determined that no other vendor supplies reagents that satisfy the technical requirements of the Olink Q100 Instrument. This procurement is conducted under the statutory authority of 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1, which applies when only one responsible source can fulfill agency requirements.

Responsible sources may submit capability statements for consideration by 12:00 PM Eastern Standard Time on June 21, 2026. The government will evaluate all responses received by the deadline to determine if a competitive procurement is appropriate, though the final decision remains within the government's discretion. Documentation associated with this notice includes two attachments posted on June 11, 2026: a J and A.pdf and an SSJ Olink 1 1 1 2.docx.